Related by context. All words. (Click for frequent words.) 76 log# IU mL 74 log# 73 -#.# log# copies mL 73 -#.# mg dL [002] 73 lumbar spine BMD 71 -#.# log# 71 μmol L 71 log# reduction 71 pg ml 70 ALT elevation 70 % Confidence Interval 70 IU mL 70 lopinavir r arm 70 creatinine ratio 70 mcg mL 70 mIU ml 70 alanine aminotransferase 69 ug dose 69 plasma HCV RNA 69 neutrophil counts 69 baseline HbA1c 69 lopinavir r 69 mL/min/#.# m 2 69 μg dose 69 -#.# mg dL [001] 69 baseline FEV 69 nmol liter 69 biochemical relapse 69 mg qd 69 mU liter 69 HBeAg seroconversion 69 aspartate aminotransferase 69 serum HBV DNA 68 cells uL 68 #.#/#.# mmHg [001] 68 uM 68 QTcF 68 mg TID 68 ug ml 68 alanine aminotransferase ALT 68 μg mL 68 #mg BID [003] 68 mg kg dose 68 pmol L 67 IU ml 67 HOMA IR 67 #.#/#.# mm Hg [003] 67 μg ml 67 PEG Interferon alfa 67 HIV RNA 67 ug kg 67 Median PFS 67 Peg IFN 67 REYATAZ r arm 67 CR nPR 67 oral allopurinol 67 4mg/kg 67 baseline serum creatinine 67 statistical significance p 67 clodronate 67 cEVR 67 pg mL 67 severe neutropenia 67 achieved ACR# 67 mg m² 67 CCyR 67 MADRS score 67 mcg BID 66 sUA 66 nM 66 ug mL 66 abacavir lamivudine 66 x ULN 66 serum urate 66 ritonavir boosted 66 Cmax 66 IFN α 66 8mg/kg 66 HCV RNA 66 mmol l 66 fasting plasma glucose FPG 66 neutrophil count 66 mL sec 66 Peginterferon Alfa 2a 66 nanomolar 66 tumor xenograft models 66 mcg albinterferon alfa 2b 66 μg kg 66 PSA nadir 66 #.#mg/dL 66 infliximab monotherapy 66 glycosylated hemoglobin HbA1c 66 ABC/3TC 66 monocyte chemotactic protein 66 dapagliflozin plus 66 copies mL 66 sustained virological response 66 undetectable virus HCV 66 HBeAg negative patients 66 TIMP 1 66 Crohn Disease Activity 65 Flu Cy 65 oxycodone CR 65 budesonide pMDI 65 HBV DNA 65 Hb A1C 65 PREZISTA r arm 65 #mg BID [001] 65 #.#ng/ml 65 TNF alpha IL 65 mg BID 65 5-FU/LV 65 Ishak fibrosis score 65 IGFBP 65 mcg kg 65 sustained virologic response 65 sUA levels 65 -#.# ± [002] 65 comparator arm 65 baseline neutrophil counts 65 mg RDEA# 65 pmol liter 65 peginterferon alfa 2b 65 piperacillin tazobactam 65 leukopenia 65 mg QD 65 copies ml 65 glucuronide 65 interleukin IL -6 65 mean baseline A1C 65 hypophosphatemia 65 emtricitabine tenofovir 65 SUVmax 65 HbA 1c levels 65 P = .# 65 dexamethasone Decadron 65 transaminase 65 ritonavir boosted atazanavir 65 mEq L 65 tipranavir r 65 isoprostane 65 recurrent VTE 65 REYATAZ r 65 lispro 65 mg ustekinumab 65 pT3 65 HBeAg 65 median CD4 65 complete cytogenetic response 65 HCV genotype 65 HAM D# scores 64 SGPT 64 FOLFOX6 64 microg 64 BARACLUDE ® 64 flutamide 64 REMICADE monotherapy 64 plus OBT 64 amprenavir 64 lymphocytosis 64 TAXUS p value 64 TIMP 64 albumin excretion rate 64 mL/min/#.# m2 64 PASI scores 64 chlorambucil 64 baseline A1C 64 serum HCV RNA 64 receiving INTRON 64 HBV DNA levels 64 XIENCE V PROMUS Stent 64 % CI #.#-#.# [003] 64 % CI #.#-#.# [007] 64 confidence interval #.#-#.# 64 receiving ISENTRESS 64 cisplatin vinorelbine 64 Mg Uk 64 plus dexamethasone 64 lipoprotein Lp 64 mcg QD 64 lactate dehydrogenase LDH 64 receiving VICTRELIS 64 cyclophosphamide methotrexate 64 leukocyte count 64 hemoglobin A1c HbA1c 64 tirofiban 64 femoral neck BMD 64 daunorubicin 64 hours postdose 64 ng dL 64 prednisone prednisolone plus 64 Hazard Ratio 64 3mg/kg 64 microgram kg 64 mmHg p = 64 FOLFIRI alone 64 apolipoprotein B 64 serum prostate 64 PSADT 64 adjunctive ABILIFY 64 glycated hemoglobin levels 64 ACR# response 64 placebo dexamethasone 64 hematologic toxicity 64 mmHg diastolic 64 intramuscular dose 64 adjunctive placebo 64 â ‰ ¥ 63 Acetate Rectal Suppositories 63 X ULN 63 mg/# hours 63 mean baseline HbA1c 63 virologic response 63 Q2W 63 #mg/day [002] 63 micrograms mL 63 SGOT 63 cytokeratin 63 telaprevir dosed 63 rizatriptan 63 alfa 2a 63 plus methotrexate 63 lactate dehydrogenase 63 Solid Tumors criteria 63 FOLFOX4 alone 63 DAS# [002] 63 ertapenem 63 TMC# r 63 serum cortisol 63 TRAIL R1 63 Mg Usa 63 aspartate aminotransferase AST 63 NPH insulin 63 leucopenia 63 low dose cytarabine 63 #mg QD [002] 63 LPV r 63 #mg/kg [002] 63 ARB telmisartan 63 CR CRu 63 mcg doses 63 IgG antibody 63 Viral Load 63 - -Books Market Segmentation 63 TNFalpha 63 Folfox 63 p = NS 63 FOLFOX4 63 serum potassium 63 ® fluocinonide Cream 63 CYP#A# CYP#D# 63 q8h 63 CD3 + 63 Lupuzor ™ 63 lymphocyte count 63 umol L 63 Ki# 63 indinavir 63 peginterferon alfa 2a 63 triglycerides TG 63 Chronic Hepatitis C 63 Randomized Phase 63 antibody titer 63 PegIFN RBV 63 mIU mL 63 plus prednisone prednisolone 63 placebo p = 63 Sustained virologic response 63 aminotransferases 63 triglyceride TG 63 urine albumin 63 serum triglycerides 63 morphometric vertebral fractures 63 deoxy 63 PREZISTA ritonavir 63 SVR# 63 atheroma volume 63 serum creatinine levels 63 PEG IFN 63 #mg q8h 63 HER2 expression 63 mg BID dose 63 Cholinesterase Inhibitors 63 isoenzyme 63 efavirenz EFV 63 AUA Symptom Score 63 serum concentrations 63 PROCTOCORT ® Suppository Hydrocortisone 63 intact parathyroid hormone 63 mcg kg REBETOL 63 novel VDA molecule 63 PRADAXA #mg 63 CIMZIA TM 63 q#h 63 serum aminotransferase levels 63 antiandrogen 63 seropositivity 63 ng dl 63 rFSH 63 Index CDAI 63 doxorubicin cyclophosphamide 63 hip BMD 63 achieved statistical significance 62 MIC# [001] 62 HPV-#/# 62 annualized relapse 62 atazanavir ritonavir 62 pegIFN 62 anemia hemoglobin 62 Viread Emtriva Sustiva 62 RNA copies mL 62 serum phosphorus 62 mso footer margin 62 serum urate levels 62 HCV Genotype 62 cells mcL 62 atorvastatin #mg 62 mm Hg systolic 62 viral titers 62 benazepril 62 biologic DMARD 62 virologic failure 62 NNRTI resistance 62 progesterone receptor negative 62 pCR 62 R# #mg BID 62 rs# [001] 62 Hazard Ratio HR 62 Peginterferon 62 CI -#.# 62 HBeAg positive 62 azathioprine monotherapy 62 micromolar 62 elevated transaminases 62 IIIa inhibitors 62 coinfected 62 experienced virologic failure 62 mmol L 62 highly emetogenic 62 fosamprenavir 62 PegIFN 62 binary restenosis 62 cytogenetic response 62 seronegative 62 KRAS mutations 62 achieved undetectable HCV 62 certolizumab 62 #mg/m# [001] 62 rapid virologic response 62 generalized edema 62 g dl 62 Sustained Virologic Response 62 CC genotype 62 febrile neutropenia 62 response CCyR 62 statistically significant p = 62 platelet reactivity 62 adriamycin 62 ribavirin therapy 62 azacytidine 62 neuropathy sensory 62 HbA1c levels 62 complete cytogenetic 62 treatment naive genotype 62 mg + GLY 62 relapsed MM 62 r2 = 62 lumbar spine bone 62 underwent surgical resection 62 baseline LDH 62 dehydroepiandrosterone sulfate 62 KRAS wild 62 GSTP1 62 CIN2 62 hydroxymethyl coenzyme 62 evaluable subjects 62 HBsAg 62 progression TTP 62 aminotransferase elevations greater 62 Partial Responses 62 Estimated planetary 62 TDF FTC 62 IC# = 62 serum CRP 62 plasma leptin 62 normal ULN 62 T2 lesions 62 Pharmacokinetics PK 62 ± SEM 62 transaminases 62 CI #.#-#.# [001] 62 FOLFIRI 62 LEXIVA r 62 oral antidiabetic medication 62 CK MB 62 g trans fats 62 pyrazinamide 62 humanized interleukin 6 62 undetectable HBV DNA 62 MCyR 62 mRNA expression 62 nevirapine Viramune 62 protein excretion 62 mg simvastatin 62 ACR# ACR# 62 mU L 62 evaluating tivozanib 62 statin monotherapy 62 octreotide LAR 62 CK # plasma concentrations 62 fluticasone salmeterol 62 % CI #.#-#.# [006] 62 pegylated interferon alpha 62 FluCAM 62 IGF binding 62 μg d 62 ± SD 62 g dL 62 Naive Patients 62 urate lowering therapy 62 moderate renal impairment 62 MBq 62 ng mL 62 saline placebo 62 sensitivity specificity 62 Rapid Virologic Response 62 mg/m2/day 61 K ras mutations 61 glomerular filtration rate 61 mg dosed twice 61 interferon alfa 2b 61 OGTT 61 Psoriasis Area 61 pyrexia mucositis sepsis febrile 61 plus MTX 61 dacarbazine 61 UGT#A# * 61 pooled comparator 61 ng ml 61 neutropenia dehydration dyspnea 61 diuretic chlorthalidone 61 plus GP IIb 61 DAS# remission 61 TRAIL R2 61 cell adhesion molecule 61 laboratory abnormalities 61 doxazosin 61 endometrial thickness 61 mitoxantrone chemotherapy 61 placebo p 61 detectable HCV RNA 61 mg q#h 61 mg/m2 dose 61 μg doses 61 K#N 61 TPV r 61 nmol 61 eosinophil count 61 unfractionated heparin UFH 61 sitosterol 61 Operative mortality 61 mg Lucentis 61 del 5q MDS 61 HbA 1c 61 DAS# CRP 61 median PFS 61 KRAS mutations occur 61 antibody titers 61 peripheral blood mononuclear 61 ATV RTV 61 plus glycoprotein IIb 61 #mmHg [001] 61 mg tid 61 sd = 61 lymphopenia 61 nucleotide analog 61 HT 1A 61 interferon alfa 2a 61 -#.# ± [001] 61 specific alkaline phosphatase 61 seroconverted 61 IRLS score 61 dosing cohorts 61 mEq 61 plasma concentrations 61 partial remissions 61 glulisine 61 aminotransferase ALT 61 intercellular adhesion molecule 61 aminotransferase levels 61 HCV replicon 61 TOP2A 61 statistically significant p 61 genotypic resistance 61 HAQ DI 61 Platelet counts 61 placebo PBO 61 glycosylated hemoglobin 61 nausea dehydration dyspnea 61 A1c levels 61 serum estradiol 61 #ug [001] 61 Adefovir 61 TREO + Y#O# 61 gemcitabine cisplatin 61 ACR# responses 61 #mg dose [002] 61 definite stent thrombosis 61 undetectable HCV RNA 61 Engerix B 61 5 Fluorouracil 61 uL 61 #.#mmol L [002] 61 ischemia driven 61 CIN2 + 61 splenectomized patients 61 Kaplan Meier analysis 61 mg hydrochlorothiazide 61 CYP#A# substrate 61 viral load 61 advanced adenoma 61 rs# [004] 61 Response Evaluation Criteria 61 bivalirudin monotherapy 61 corrected QT interval 61 cells μL 61 CD4 lymphocytes 61 specific antigen PSA 61 trastuzumab Herceptin R 61 abnormal p# biomarker 61 μg liter 61 Relapsed Refractory Multiple Myeloma 61 serum testosterone 61 estramustine 61 mmHg systolic 61 mg Androxal 61 administered subcutaneously 61 #mg/dL [002] 61 titrated glipizide plus 61 liver histology 61 ALVESCO 61 Non Responders 61 CrCl 61 Scale cognitive subscale 61 recurrent venous thromboembolism 61 μg L 61 HBeAg negative 61 sunitinib Sutent ® 61 HLA DR2 61 ERalpha 61 tenofovir emtricitabine 61 Demonstrated Significant 61 LPS induced 61 FluCAM arm 61 mg Proellex 61 CD4 + cell 61 pegylated interferon alfa 2a 61 plus medroxyprogesterone acetate 61 -#.# mmol L 61 hsCRP levels 61 HbA1C 61 Virologic 61 MMSE score 61 ‰ ¥ 61 baseline CD4 61 Selective Inhibitor 61 tPSA 61 gemcitabine carboplatin 61 ribavirin RBV 61 HbA1C levels 61 UNCERTAINTY OF FUTURE FINANCIAL 61 concentration Cmax 61 Pred Forte 60 microbiological eradication 60 glycated hemoglobin HbA1c 60 retinol binding protein 60 P ≤ 60 carboplatin paclitaxel 60 invasive carcinomas 60 total cholesterol LDL 60 interleukin IL 60 virologic failures 60 APTIVUS r 60 lamivudine monotherapy 60 Cream USP 1 60 5 FU leucovorin 60 imipenem 60 Rating Scale MADRS 60 interferon alfa 60 PEGylated anti 60 Viread Emtriva 60 inflammatory lesions 60 Oral Fingolimod 60 fructosamine 60 cis retinoic acid 60 confidence intervals CIs 60 #OHD 60 adalimumab Humira 60 adefovir 60 colorectal carcinomas 60 elevated ALT 60 fluorouracil leucovorin 60 Montgomery Asberg Depression 60 corticosteroid dose 60 hydroxyvitamin D levels 60 TO AVOID PREGNANCY WHILE 60 NovoLog ® Mix 60 PaO 2 60 VELCADE melphalan 60 steroid dexamethasone 60 CD4 CD8 60 grams dietary fiber 60 IIIa inhibitor 60 poor metabolizers 60 confidence interval CI 60 advanced adenomas 60 nodular partial response 60 mCi 60 rosuvastatin #mg 60 tipranavir ritonavir 60 undetectable viral 60 #mg/day [001] 60 nicardipine 60 Pharmacokinetic parameters 60 virological response 60 mitoxantrone plus 60 plasminogen activator inhibitor 60 univariate analysis 60 biochemical recurrence 60 leukocytosis 60 #μg [002] 60 serum albumin 60 hemoglobin A1c levels 60 seropositive patients 60 plasma uric acid 60 plasma renin activity 60 HCV genotypes 60 dasatinib Sprycel ® 60 TEAEs 60 CDAI score 60 XIENCE V vs. 60 p = .# [002] 60 nadolol 60 receiving golimumab 60 ptau 60 AUC0 60 BENICAR HCT 60 g carbo 60 mg kg Hematide 60 colorectal carcinoma 60 mm ³ 60 Janus kinase 60 mcg linaclotide 60 candesartan cilexetil 60 Interferon gamma 60 erlotinib Tarceva ® 60 chronic HCV genotype 60 achieved sustained virological 60 HDRS 60 QD dosing 60 adenosine diphosphate ADP 60 ADCS CGIC 60 nucleoside naive 60 anti HBs 60 FOLFOX 60 Contrave# 60 intima media thickness 60 p# antigen 60 EGFR TKI 60 mcg ml 60 ErbB2 positive 60 imiquimod cream 60 serum phosphate 60 mg/m2 IV 60 trimethoprim sulfamethoxazole 60 serum ALT 60 CIN3 60 dasatinib Sprycel 60 serum IGF 60 bFGF 60 CIN3 + 60 Supplementary Table 60 pegylated liposomal doxorubicin 60 ALT flares 60 β blocker 60 hypokalemia 60 thyroglobulin 60 micromoles 60 Hycamtin ® 60 highest tertile 60 #.#mmol L [001] 60 % CI #.#-#.# [001] 60 monocytic 60 fasting plasma glucose 60 #R #R #R [002] 60 AEGR 60 CYT# potent vascular disrupting 60 interquartile range 60 cGy 60 median survivals 60 triiodothyronine 60 heterozygotes 60 C Reactive Protein 60 IFN alpha 60 microvessel density 60 Immunohistochemical staining 60 RGT arm 60 salmeterol fluticasone propionate 60 achieved CCyR 60 p = 60 AZT zidovudine Retrovir 60 pimecrolimus cream 60 Tipranavir 60 anthracycline taxane 60 mg dose 60 tamoxifen Nolvadex ® 60 CLL SLL 60 gram dietary fiber 60 Insulin Glargine 60 caspofungin 60 Pegasys plus Copegus 60 stage IIIb IV 60 sodium glucose cotransporter 60 mg/# h 60 fasting triglycerides 60 mm Hg diastolic 60 ANCOVA 60 peripheral sensory neuropathy 60 receiving PEGINTRON 60 serum PTH 60 PREMPRO 60 inhibin B 60 Kinoid 60 mg subcutaneously 60 ALT elevations 60 virus HCV protease inhibitor 60 daily Infergen 60 CTAP# Capsules 60 noncarriers 60 tHcy 60 HT 2A 60 odds ratios ORs 60 hematological parameters 60 regulated kinase 60 hemoglobin Hb 60 adefovir treated 60 iPTH 60 virologic responses 60 confirmed CCyR 60 AUA BPH Symptom Score 60 Interferon beta 1b 60 lowest tertile 60 titers 60 mycophenolate mofetil 60 Elitek 60 Left Ventricular Ejection Fraction 60 treatment naïve genotype 60 MLH1 60 grams saturated 60 adenoma recurrence 60 bronchoalveolar lavage 60 Banania Brittney 60 Eur J Endocrinol 60 anaphylactic reactions bronchospasm 60 estimated glomerular filtration 60 hepatic enzymes 60 Viral load 60 Febrile neutropenia 60 BMS p = 60 dose cohort 60 glutamyl 59 Camptosar ® 59 COMBIVIR 59 antiretroviral naïve 59 immunoreactivity 59 malignancy HCM 59 HGPIN 59 IPSS 59 MAGE A3 ASCI 59 lopinavir 59 mg orally 59 FUSILEV enhances 59 creatinine levels 59 virologic response EVR 59 ® emtricitabine 59 systolic diastolic blood 59 mmol kg 59 Fasting blood glucose 59 creatinine clearance 59 mg/#.# mg [001] 59 Treatment Naive Patients 59 HBeAg positive patients 59 nonsignificant difference 59 Capacity FVC 59 autoantibody levels 59 dose dependently 59 - -opera Wozzeck 59 mol L 59 risedronate Actonel 59 muscarinic 59 multivariate Cox 59 LANTUS R 59 lymphocyte counts 59 Pegylated Liposomal Doxorubicin 59 thrombosis embolism 59 Index CDAI score 59 #.#-#.# [011] 59 Dasatinib 59 maternal serum 59 elevated LDH 59 albumin excretion 59 μM 59 urinary albumin 59 invasive ductal 59 Plus Ribavirin 59 Scale EDSS score 59 fluvastatin 59 myeloperoxidase 59 clinically meaningful improvement 59 CRp 59 ACTEMRA TM 59 cm flux 59 alfa 2b 59 Thal Dex 59 plus prednisone 59 echocardiographic parameters 59 ALT normalization 59 Interferon alfa 59 mIU L 59 Pooled Analysis 59 p = #.# [003] 59 epoetin beta 59 HER2 amplification 59 ara C 59 - -Schwenkler 59 INCOME TAX EFFECTS 59 μg dL 59 HOLE NO 59 % CI #.#-#.# [008] 59 mcg kg min 59 symptomatic intracranial hemorrhage 59 Copegus ribavirin 59 docetaxel chemotherapy 59 ULORIC 59 nadroparin 59 mcg dose 59 mcg dL 59 tolterodine ER 59 quetiapine risperidone 59 fasting insulin 59 multivariable adjusted 59 BUPHENYL R sodium phenylbutyrate 59 mmol liter 59 p ≤ 59 peginterferon alfa 2a Pegasys 59 EARNINGS IN RETROSPECT 59 cTnI 59 mg p = 59 naïve HCV 59 plus aztreonam 59 hemagglutination inhibition 59 irinotecan cisplatin 59 selective agonist 59 mutated K ras 59 apolipoprotein E4 59 polyunsat 59 ß = 59 Alzheimer Disease Assessment 59 HLA DR 59 Partial Response 59 rheumatoid factor 59 ml min 59 transaminase elevations 59 fraction LVEF 59 #.#g/day 59 +3 bps 59 pg g 59 Biaxin clarithromycin 59 prednisone prednisolone 59 cisplatin gemcitabine 59 Pegasys ® 59 AST ALT 59 colesevelam HCl 59 HI titers 59 dalteparin 59 transcriptase inhibitors 59 homozygotes 59 concomitant medications 59 CsA 59 EpCAM expression 59 F FLT 59 Protease Inhibitors 59 recurrent genital herpes 59 Stomatitis 59 nmol L 59 Factor Receptor 59 HCV SPRINT 59 nonnucleoside reverse transcriptase inhibitors 59 DJI #.# 59 #-#,# mg 59 NNT = 59 Noncritical violations found 59 #Gy 59 extrapyramidal symptoms 59 serum uric acid 59 leukemia AML 59 estrogen receptor progesterone receptor 59 mg XP# 59 LVEF 59 mCi kg 59 lamivudine 3TC 59 fasting plasma 59 blood Phe 59 HbA1c 59 leuprorelin 59 YMRS 59 viral titer 59 calculated creatinine clearance 59 Hazard Ratio = 59 LH FSH 59 http:/events.fai.org 59 interleukin IL -# 59 F FDG PET 59 peginterferon alfa 59 Pegylated Interferon 59 Prolongs Survival 59 methotrexate monotherapy 59 peginterferon alpha 2a 59 monocyte chemoattractant protein 59 XELOX 59 % CI #.#-#.# [005] 59 mCi m 2 59 adiponectin concentrations 59 mg d 59 #.#-#.# UP 59 plus ribavirin 59 OS = ISD/#/#/# 59 SCr 59 gemcitabine Gemzar 59 Median progression 59 Macrophage 59 Leukemias 59 bioavailable testosterone 59 DFMO 59 plus COPEGUS 59 coronary stenosis 59 serum magnesium 59 Ejection Fraction 59 COZAAR 59 % miconazole nitrate 59 Suppository Hydrocortisone Acetate Rectal 59 interferon ribavirin 59 cervical intraepithelial neoplasia 59 scores TNSS 59 receptor blocker 59 NMIBC 59 PEGASYS ® 59 serum calcium levels 59 μmol l 59 baseline Hb 59 mmol L. 59 locoregional recurrence 59 triglyceride concentrations 59 Hepatitis C Genotype 59 serum phosphorous 59 FDG uptake 59 3mg 59 seroconversion 59 zoledronate 59 undetectable viral load 59 GSTM1 59 ECOG PS 59 receiving prophylactic anticoagulation 59 % CI #.#-#.# [004] 59 #mg BID [002] 59 CD# + [001] 59 acarbose 59 cytidine nucleoside analog 59 GG genotype 59 azathioprine 59 urinary N telopeptide 59 total cholesterol triglycerides 59 ml kg 59 CHANGE WEEKLY CHANGE 59 irbesartan 59 haematologic 59 mU 59 Decitabine 59 TP# mutations 59 preoperative PSA 59 pT2 59 LRAT 59 RLAI 59 μg g 59 ceftazidime 59 Voter Abstentions 59 promoter methylation 59 antigen PSA levels 59 metastatic malignant